RAIN stock forecast
Our latest prediction for Rain Oncology Inc's stock price was made on the June 6, 2023 when the stock price was at 1.25$.
In the short term (2weeks), RAIN's stock price should underperform the market by -4.07%. During that period the price should oscillate between -12.34% and +11.54%.
In the medium term (3months), RAIN's stock price should underperform the market by -13.31%. During that period the price should oscillate between -32.09% and +23.23%.
Get email alertsCreate a solid portfolio with RAIN
About Rain Oncology Inc
rain therapeutics is a san francisco bay area-based biotechnology company, focused on developing small molecule targeted therapeutics for cancer patients that possess a clear, and single, oncogenic driver.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of None$ per share.
The book value per share is -1.44$
Three months stock forecastJune 6, 2023
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -81M | - | -55M | - | - | - | 36M | -1.44 | - | - | - |